oasis 1 semaglutide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Oral Semaglutide for Treatment of

It may be appropriate for adults who meet prescribing criteria for chronic weight management, including some adults with obesity and moderate to severe obstructive sleep apnea

The Indian government plans to offer incentives to promote local manufacturing of GLP-1 drugs by 2026, which will impact pricing and availability. Brazil In Brazil, the first generics of semaglutide (Ozempic) will launch in March 2026 after Novo Nordisks patent expires

Burrone J, Murthy VN (2003)

Activation of the PPAR pathway negatively affects fat formation by downregulating the expression of genes associated with new fat formation

Semaglutide: The Second-Generation Leap Semaglutide, approved for weight management as Wegovy in 2021, represents a fundamentally different level of molecular engineering

See your GP